Brentuximab Vedotin for Named Patient Import

Brentuximab (Adcetris) for Named Patient Import

Brentuximab (Adcetris) is an FDA Approved medication recommended for the treatment of various Haematological Malignancies, otherwise known as Blood Disorders. Developed by Seattle Genetics, manufactured and marketed by Takeda, this drug is globally available by the trade name - Adcetris. Brentuximab or Adcetris in India is yet to be approved and therefore Indian Patients can access Brentuximab only through legal channels of Import.

Adcetris is commercially available as 50mg Vial. Indian Patients who are recommended for treatment with Brentuximab can avail Named Patient Import Permit and legally import the same for personal use.

Brentuximab (Adcetris) in India? We can help

If you are a patient in India, looking for authentic global sources, we are the best avenue for you. Our team has vast experience of supporting Indian Patients. We assist you with all the necessary procedures and also help contacting the most reliable international suppliers. These are licensed suppliers, specifically handling the Import and Export of advanced lifesaving medicines like Brentuximab or Adcetris.

Write to us at nhs@noelbiotech.com or contact us on + 91 9677010046 / + 91 9929277766.